- Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer
- Enanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024
- Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
- Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference
- Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET
- Enanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
More ▼
Key statistics
On Wednesday, Enanta Pharmaceuticals Inc (ENTA:NSQ) closed at 13.56, 67.82% above the 52 week low of 8.08 set on Nov 10, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 13.73 |
---|---|
High | 14.27 |
Low | 13.51 |
Bid | 12.84 |
Offer | 14.83 |
Previous close | 13.74 |
Average volume | 122.20k |
---|---|
Shares outstanding | 21.16m |
Free float | 19.87m |
P/E (TTM) | -- |
Market cap | 290.68m USD |
EPS (TTM) | -6.56 USD |
Data delayed at least 15 minutes, as of May 01 2024 21:00 BST.
More ▼